Evidence map›Paper›PMID 31080338›Full record

ArticleP & T : a peer-reviewed journal for formulary management2019

Regulatory and Legislative Disparities With Cannabis Present Challenges to P&T Committees and Health Care Providers.

Rita Marcoux, Lauren Holmes, F Randy Vogenberg, BSc Pharm

Abstract read
In one paragraph

Article in P & T : a peer-reviewed journal for formulary management, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Beyond Medical Cannabis: Considerations for Updates to Hospital Policies and Procedures.P & T : a peer-reviewed journal for formulary management · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rita Marcoux
Lauren Holmes
F Randy Vogenberg
BSc Pharm

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased cannabis use has brought about a sea change in policy and attitudes toward regulation, and a multitude of rules that vary widely between states. The disparity has stymied any effective response to the problems surrounding access to cannabis products for those in need. Health care providers and practitioners, as well as P&T committees, must carefully undertake decisions on rational drug use, whether or not their patients are using cannabis while under their care.

Indexed as

2018 Farm Bill (FB)Board of Pharmacy (BOP)cannabidiol (CBD)Controlled Substance Act (CSA)Controlled Substance Schedule I (CI)Prescription Drug Monitoring Program (PDMP)tetrahydrocannabinol (THC)

Identifiers

PMID31080338
PMCPMC6487971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.